Education
About Us
Working with TipRanks
Follow Us
Lexston Life Sciences Corp. (TSE:LEXT)
:LEXT
RESEARCH TOOLSreports
Total Valuation
Lexston Life Sciences Corp. has a market cap or net worth of C$1.14M. The enterprise value is C$1.10M.
Market CapC$1.14M
Enterprise ValueC$1.10M
Share Statistics
Lexston Life Sciences Corp. has 7,362,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding7,362,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Lexston Life Sciences Corp.’s return on equity (ROE) is -1.22 and return on invested capital (ROIC) is -94.89%.
Return on Equity (ROE)-1.22
Return on Assets (ROA)-1.16
Return on Invested Capital (ROIC)-94.89%
Return on Capital Employed (ROCE)-0.95
Revenue Per Employee―
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Lexston Life Sciences Corp. is -39.09. Lexston Life Sciences Corp.’s PEG ratio is 1.22.
PE Ratio-39.09
PS Ratio0.00
PB Ratio47.70
Price to Fair Value47.70
Price to FCF-46.90
Price to Operating Cash Flow-64.83
PEG Ratio1.22
Income Statement
In the last 12 months, Lexston Life Sciences Corp. had revenue of 0.00 and earned -867.71K in profits. Earnings per share was -0.02.
Revenue0.00
Gross Profit-26.39K
Operating Income-674.72K
Pretax Income-734.28K
Net Income-867.71K
EBITDA-648.32K
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -1.27M and capital expenditures -199.99K, giving a free cash flow of -1.47M billion.
Operating Cash Flow-1.27M
Free Cash Flow-1.47M
Free Cash Flow per Share-0.20
Dividends & Yields
Lexston Life Sciences Corp. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.25
52-Week Price Change-84.21%
50-Day Moving Average0.31
200-Day Moving Average0.44
Relative Strength Index (RSI)37.92
Average Volume (3m)3.22K
Important Dates
Lexston Life Sciences Corp. upcoming earnings date is Sep 22, 2025, TBA Not Confirmed.
Last Earnings DateApr 15, 2025
Next Earnings DateSep 22, 2025
Ex-Dividend Date―
Financial Position
Lexston Life Sciences Corp. as a current ratio of 11.37, with Debt / Equity ratio of 22.14%
Current Ratio11.37
Quick Ratio11.37
Debt to Market Cap0.00
Net Debt to EBITDA0.60
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Lexston Life Sciences Corp. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Lexston Life Sciences Corp. EV to EBITDA ratio is -51.71, with an EV/FCF ratio of -46.36.
EV to Sales0.00
EV to EBITDA-51.71
EV to Free Cash Flow-46.36
EV to Operating Cash Flow-64.09
Balance Sheet
Lexston Life Sciences Corp. has C$50.47K in cash and marketable securities with C$0.00 in debt, giving a net cash position of C$79.53K billion.
Cash & Marketable SecuritiesC$50.47K
Total DebtC$0.00
Net CashC$79.53K
Net Cash Per ShareC$0.01
Tangible Book Value Per ShareC$0.02
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Lexston Life Sciences Corp. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-36.54%